GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site)
Financial Results:
Glaxosmithkline Pharmaceuticals Ltd reported Revenues for Q4FY24 of ₹930.00 Crores up from ₹787.00 Crore year on year, a rise of 18.17%.
Total Expenses for Q4FY24 of ₹692.00 Crores up from ₹636.00 Crores year on year, a rise of 8.81%.
Consolidated Net Profit of ₹194.00 Crores up 45.86% from ₹133.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹11.48, up 45.69% from ₹7.88 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.